Send the following on WhatsApp
Continue to Chat歌禮宣佈ASC22(恩沃利單抗)用於HIV-1型感染免疫重建/功能性治癒的II期臨床試驗完成首例受試者給藥 https://geneonline.news/%e6%ad%8c%e7%a6%ae%e5%ae%a3%e4%bd%88asc22%ef%bc%88%e6%81%a9%e6%b2%83%e5%88%a9%e5%96%ae%e6%8a%97%ef%bc%89%e7%94%a8%e6%96%bchiv-1%e5%9e%8b%e6%84%9f%e6%9f%93%e5%85%8d%e7%96%ab%e9%87%8d%e5%bb%ba-%e5%8a%9f/